What it is (one line): a venture firm Peter Diamandis co-founded with Yianni Psaltis, PhD. It invests in Colossal Biosciences and in companies built on Colossal's platform.
Updated 2026-10-29. Refreshed monthly, and whenever a Moonshots with Peter Diamandis episode names it.
Why it is in this archive
Gate: named in two held episodes, with no page until now. On Moonshots #288 2:24:30 (caption "Neoenesis") the host calls it "a new company, another portfolio company… using the intersection of AI and synthetic biology to design the genotype that delivers the phenotype". On Moonshots #306 1:35:13–1:35:36 he calls it "my own fund, Neoenesis… a $200 million fund that I started with Dr. Yanni Palis. It's investing in Colossal and all the spinouts, including Warhound". That second line resolves the Aspiration: investigate row the Moonshots: the disclosures ledger ledger had carried since EP288.
Facts
| item | value | source |
|---|---|---|
| Fund vehicle | NeoGenesis Capital Fund I, LP. Pooled investment fund (venture). Related person: Peter Harry Diamandis, Executive Officer and Director, the only one named | Form D, filed 2026-07-01, read 2026-10-29 |
| Amount sold | $33,080,000. First sale 2026-06-18. Total offering amount "Indefinite" | same Form D |
| Launch | announced 14–15 Oct 2026, "in partnership with Yianni Psaltis, PhD, investing in Colossal". Written disclosure: "We are co-founders of NeoGenesis Capital and have a financial interest in the firm" | his Metatrends post, 15 Oct (read on the Peter Diamandis page) |
| Portfolio (its own page, 17 Oct) | Colossal, Breaking, Astromech, one stealth company | neogenesiscapital.com, via Colossal Biosciences |
| Warhound | a NeoGenesis investment, said on tape. Warhound came out of stealth ~22 Oct with a $200M seed at $1.2B, from In-Q-Tel, Sequoia, 8VC, ARK, Franklin Templeton, Breyer and NeoGenesis, among others | Moonshots #306 1:35:13; TechCrunch via secondary outlets (verification pass, 2026-10-29) |
| Independence language | Lamm and Church hold no economic interest in NeoGenesis; "Colossal and its affiliates have not endorsed or sponsored the fund" | neogenesiscapital.com, via Colossal Biosciences |
What the tape says against the documents
- "$200 million fund" (EP306): the Form D shows $33.08M sold with the offering size left "Indefinite". $200M may be a target, but neither the filing nor the launch post found says so. 🔴 Don't repeat the size.
- "I think I haven't mentioned this on the pod" (EP306): it was said on EP288, described as a company.
- Co-founder name: the caption's "Dr. Yanni Palis" is Yianni Psaltis, per the host's own post. The Form D names only Diamandis.
- What it means for the ledger: every Colossal, Colossal spin-out or Warhound story the host reads is now a story about a company his fund holds. On the Moonshots #297 Ben Lamm guest segment that was not said. On EP306 it was, before the story.
Open
- Is $200M the target size, and is there a Form D/A with a later amount sold?
- The stealth portfolio company: is it Warhound?
- Psaltis's background (not researched here).
How this page stays current
Monthly: re-check EDGAR for a Form D/A, and re-read the portfolio page. Per episode: any Colossal, Astromech, Breaking or Warhound mention gets a re-disclosure check in Moonshots: the disclosures ledger.
Related
Peter Diamandis · Colossal Biosciences · Ben Lamm · Palmer Luckey · Moonshots: the disclosures ledger